STOCK TITAN

Harmony Biosciences Announces Date of Third Quarter 2021 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) announced it will release its third quarter 2021 financial results on November 9, 2021. A conference call will follow at 8:30 a.m. ET on the same day. To join, participants can dial (833) 614-1471 (domestic) or +1 (914) 987-7209 (international) using passcode 4387084. A replay will be available after the call and can be accessed until November 16, 2021. Harmony focuses on innovative therapies for rare neurological diseases and is committed to addressing unmet medical needs.

Positive
  • None.
Negative
  • None.

PLYMOUTH MEETING, Pa., Oct. 26, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that it will issue a press release on the Company's third quarter 2021 financial results on Tuesday, November 9, 2021. Following the release, Harmony will conduct a conference call and live webcast on the same day, at 8:30 a.m. ET.

To participate in the call, please dial (833) 614-1471 (domestic) or +1 (914) 987-7209 (international), and reference passcode 4387084. It is recommended that you dial in at least 10 minutes prior to the call.

The live and replayed webcast of the call will be available on the investor page of our website at https://ir.harmonybiosciences.com/.

A replay of the call will be available within 24 hours by dialing (855) 859-2056 (domestic) or +1 (404) 537-3406 (international) and entering conference ID: 4387084. The replay will be available until November 16, 2021.

About Harmony Biosciences
Harmony Biosciences is a commercial stage pharmaceutical company headquartered in Plymouth Meeting, PA. The Company was established by Paragon Biosciences, LLC, and is focused on providing novel treatment options for people living with rare neurological diseases who have unmet medical needs. For more information on Harmony, please visit the company's website: www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:
Patti Bank
415-513-1284
ir@harmonybiosciences.com 

Harmony Biosciences Media Contact:
Nancy Leone
215-891-6046
nleone@harmonybiosciences.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-announces-date-of-third-quarter-2021-financial-results-301408119.html

SOURCE Harmony Biosciences

FAQ

When will Harmony Biosciences announce its Q3 2021 financial results?

Harmony Biosciences will announce its Q3 2021 financial results on November 9, 2021.

What time is the Harmony conference call for Q3 2021 results?

The conference call for Q3 2021 results will be held at 8:30 a.m. ET on November 9, 2021.

How can I participate in the Harmony Biosciences conference call?

To participate, dial (833) 614-1471 (domestic) or +1 (914) 987-7209 (international) and use passcode 4387084.

When will the replay of the Harmony conference call be available?

The replay will be available within 24 hours after the call and can be accessed until November 16, 2021.

Harmony Biosciences Holdings, Inc.

NASDAQ:HRMY

HRMY Rankings

HRMY Latest News

HRMY Stock Data

1.94B
38.55M
11.62%
93.1%
10.17%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
PLYMOUTH MEETING